Scarica l'app Stockscreener
0.00
100.00%
-0.6063
Precedente Chiudi:
$0.6063
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$82.91M
Reddito:
$247.99M
Utile/perdita netta:
$-521.97M
Rapporto P/E:
0.00
EPS:
-1.11
Flusso di cassa netto:
$-194.28M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
$0.00
$0.00
Intervallo di 1 settimana:
$0.00
$0.00
Portata 52W:
$0.00
$10.81
23 Andme Holding Co Stock (ME) Company Profile
Nome
23 Andme Holding Co
Settore
Industria
Telefono
(650) 938-6300
Indirizzo
223 N. MATHILDA AVE., SUNNYVALE
Confronta ME con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ME
23 Andme Holding Co
|
0.00 | 82.91M | 247.99M | -521.97M | -194.28M | -1.11 |
|
TMO
Thermo Fisher Scientific Inc
|
408.84 | 150.38B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
202.56 | 137.52B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
524.88 | 42.00B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
117.78 | 32.37B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
158.10 | 25.50B | 15.50B | 1.33B | 2.16B | 7.34 |
23 Andme Holding Co Stock (ME) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-11-29 | Iniziato | Berenberg | Buy |
| 2022-09-22 | Iniziato | Cowen | Outperform |
| 2021-11-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-08-17 | Iniziato | Credit Suisse | Outperform |
| 2021-07-12 | Iniziato | Citigroup | Buy |
23 Andme Holding Co Borsa (ME) Ultime notizie
23andMe Ombudsman Not Confident Sale Is Lawful - Law360
Ocasio-Cortez leads congressional call for genetic data safeguards amid 23andMe bankruptcy - Bronx Times
23andMe Privacy Ombudsman Urges User Consent Pre-Data Sale (1) - Bloomberg Law News
Senate holds hearing on 23andMe, concerns over company selling customers’ data (Video) - Social News XYZ
Congress Grills 23andMe on Data Privacy as States Take Legal Action Over Company Sale - The HIPAA Journal
IP, Health Law Scholars Object To 23andMe Ch. 11 Data Sale - Law360
23andme genetic privacy concerns garner Congressional scrutiny - BioWorld MedTech
23andMe Holding Co. SEC 10-K Report - TradingView
Senator Calls For 23AndMe Customers To Sue Company 'Into Oblivion' - Newsweek
Senate holds hearing on 23andMe, concerns over company selling customers' data - CBS News
States Sues To Block 23andMe From Selling DNA Data In Ch. 11 - Law360
23andMe (MEHCQ) Faces Legal Challenge Over Genetic Data Sale - GuruFocus
23andMe Privacy Reviewer’s Law Firm Discloses Work for Regeneron - Bloomberg Law News
US states sue 23andMe to protect customers' private data - marketscreener.com
23andMe sued by state attorneys general over plans to sell genetic data - Seeking Alpha
New York AG sues 23andMe to protect customers' private data - marketscreener.com
23andMe’s Proposed Banruptcy Sale Prompts Challenge From States - Bloomberg Law News
23andMe seeks second auction as ex-CEO outbids Regeneron - MSN
23andMe Reopens Bidding, Jackson Walker Mediates Fee Suit - Law360
Millennium Management LLC Has $720,000 Holdings in 23andMe Holding Co. (NASDAQ:ME) - Defense World
The New Twist In Regeneron's 23andMe Bankruptcy Buyout - Investor's Business Daily
Bankruptcy Was Good for 23andMe - Bloomberg.com
23andMe Sets New Auction With $305 Million New Bid From Ex-CEO - Bloomberg
23andMe’s DNA Data Soars in Value With New $305 Million Bid - MSN
23andMe (MEHCQ) Faces Second Auction as Former CEO Bids $305M - GuruFocus
23andMe’s DNA data gets boosted $305m bid in new auction - Moneyweb
Genetic testing company 23andMe to re-auction over 15 million customers' DNA data with bid starting at $305mn — Details - Mint
23andMe’s DNA data gets boosted USD 305m bid in new auction - medwatch.com
23andMe, Bidders Agree To Post-Ch. 11 Auction Offer Process - Law360
23andMe seeks new bids after $305 million offer from its co-founder - Reuters
23 and You: The Privacy and National Security Implications of the 23andMe Bankruptcy - Senate Committee on the Judiciary (.gov)
23andMe Judge Questions Limits for New Auction for Bankrupt Firm - Bloomberg
Northern Trust Corp Sells 562,535 Shares of 23andMe Holding Co. (NASDAQ:ME) - Defense World
Canada Customers Agree To Halt 23andMe Data Breach Suits - Law360
23andMe Bankruptcy Judge Ponders Trump Bill’s Injunction Impact - Bloomberg Law News
23andMe Founder Pushes Alternative Ch. 11 Sale - Law360
23andMe founder aims to restart auction with major corporate backing - Reuters
Regeneron to buy bankrupt 23andMe, vows ethical use of customer DNA data (May 19) - marketscreener.com
Here’s how to file a claim amid 23andMe bankruptcy - FOX4KC.com
Anne Wojcicki plans to object to 23andMe's bankruptcy court sale - The Business Journals
23andMe to delist from Nasdaq and deregister with SEC By Investing.com - Investing.com South Africa
23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC - GlobeNewswire
23andMe Agrees To Sale, Rite Aid Pharmacy Deals Get OK - Law360
23Andme Announces Intent To Voluntarily Delist From Nasdaq & Deregister With SEC - marketscreener.com
23andMe to delist from Nasdaq and deregister with SEC - Investing.com Australia
23andMe Takes Final Step to Exit Nasdaq: Voluntary Delisting After March Bankruptcy Filing - Stock Titan
Jane Street Group LLC Has $836,000 Stock Position in 23andMe Holding Co. (NASDAQ:ME) - Defense World
Senators Unveil DNA Privacy Bill Amid 23andMe's Ch. 11 Sale - Law360
23andMe Holding Co. (OTC:MEHCQ) Was Worth A Lot More Than People Thought, Says Jim Cramer - MSN
23 Andme Holding Co Azioni (ME) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.96%
1.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):